Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Report

Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-552-6
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the real-time pcr, digital pcr, and end-point pcr market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for real-time pcr, digital pcr, and end-point pcr market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of real-time pcr, digital pcr, and end-point pcr market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Real-time PCR, Digital PCR, And End-point PCR Market Categorization:

The real-time pcr, digital pcr, and end-point pcr market was categorized into four segments, namely technology (Quantitative, Digital, End-point), application (Clinical, Research, Forensic), product,(Consumables & Reagents, Instruments, Software & Services) and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The real-time pcr, digital pcr, and end-point pcr market was segmented into technology, application, product, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The real-time pcr, digital pcr, and end-point pcr market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Real-time pcr, digital pcr, and end-point pcr market companies & financials:

The real-time pcr, digital pcr, and end-point pcr market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Abbott, Abbott was established in 1888 and is headquartered in the U.S. Abbott Laboratories has four core business segments: pharmaceuticals, devices, nutrition, and diagnostics. The company has a presence in more than 160 countries with research, manufacturing, sales, and distribution facilities. The diagnostic segment provides diagnostic systems, reagents, and tests for various applications. The company offers products based on technologies, such as PCR, fluorescence in situ hybridization, and DNA & RNA sequencing. As of December 2019, the company employed 107,000 people globally.

  • Qiagen, Qiagen is a holding company that caters to the biotechnology industry. Qiagen provides samples and assay technologies for academic research, applied testing, molecular diagnostics, and pharmaceutical research. The company markets over 500 products including consumable kits and automation systems. Qiagen products for molecular diagnostics cover relevant areas of healthcare ranging from early diagnosis of diseases, establishment of diagnosis, diagnostic testing for determination of suitable treatment, and point-of-need testing. The company’s customers include healthcare providers, pharmaceutical & biotechnology companies, government or industrial customers, and researchers. As of December 2019, 5,200 employees were working in the company. Qiagen has direct operations in 34 nations.

  • Bio-Rad Laboratories, Inc., Bio-Rad Laboratories, Inc. manufactures systems and products used to separate complex biological & chemical materials and analyze, identify, & purify their respective components. The company operates through two segments: clinical diagnostics and life sciences. The clinical diagnostics segment includes informatics systems, test systems, quality controls, and test kits. Similarly, the life sciences segment is employed in the creation and discovery of tools required in biological processes. The company manufactures reagents, apparatus, and laboratory instruments that are used in the process of biopharmaceutical production, research techniques, and food testing regimes. Primary users of Bio-Rad products include hospitals, research institutions, laboratories, biotechnology companies, and pharmaceutical firms. The company has direct distribution channels in approximately 35 countries. The company had 8,120 employees as of December 2019.

  • Agilent Technologies, Inc., Agilent Technologies, Inc. is involved in providing analytical instruments & software for analytical scientists & clinical researchers. The company has operations in pharmaceuticals, food, chemical & energy, environmental & forensics, and research segments. Its life sciences and applied market segment offers liquid & gas chromatography, mass spectrometry, spectroscopy, genomics & diagnostic consumables, services, and software. This company was formed in 1999 after it spun off from Hewlett-Packard. It delivers its products through direct sales, resellers, distributors, electronic commerce, and representatives of manufacturers. It has operations across the globe including the Americas, Europe, Africa, and Asia Pacific. The company’s diagnostics business includes companion diagnostics, nucleic acid contract manufacturing & pathology, genomics, and reagent partnership businesses. Its genomics portfolio includes genotyping, DNA methylation profiling, identification of gene rearrangements, gene expression profiling, gene copy number determination, arrays for DNA mutation detection, NGS target enrichment, and genetic data management & interpretation support software.

  • Thermo Fisher Scientific, Inc., Thermo Fisher Scientific, Inc. manufactures and supplies scientific equipment, analytical instruments, and other laboratory equipment. The company operates in pharmaceutical and biotechnology, industrial & applied research, diagnostics & healthcare, and academic & government segments. Thermo Fisher Scientific provides chromatographs, Erlenmeyer flasks, gene sequencers & spectrometers, clinical analytical tools, and diagnostic testing products. The company serves more than 400,000 customers around the world through its brands such as Applied Biosystems, Fisher Scientific, Thermo Scientific, Unity Lab Services, and Invitrogen. It is headquartered in the U.S. and employed more than 75,000 people as of 2019.

  • Affymetrix, Affymetrix, Inc. is an American company that manufactures DNA microarrays. The company is headquartered in Santa Clara, California, U.S. Affymetrix was acquired by Thermo Fisher Scientific, Inc. in March 2016. Its product line includes innovative technologies that allow parallel and multiplex analysis of biological systems at protein, cell, and gene levels. Its microarray solutions comprise all important components that are required for a microarray experiment, from reagents and arrays to software and instruments, allowing clinicians and scientists to understand underlying disease mechanisms, identify biomarkers for personalized medicine, and create novel molecular diagnostic tests.

  • Cytiva (GE Healthcare), Cytiva (GE Healthcare) changed its name from GE Healthcare Life Sciences in April 2020. GE Healthcare was incorporated in 1951 and is headquartered in Chicago, U.S. It is engaged in manufacturing and developing diagnostic solutions, bioprocessing, genomics, protein research, lab filtration, cellular therapy, and cell & gene therapy. The company offers services such as technology solutions for drug discovery, medical equipment, and solutions for clinicians & healthcare administrators. The company employs around 7,000 people worldwide. Moreover, it has a presence in over 40 nations globally.

  • bioMérieux SA, bioMérieux SA is a multinational biotechnology company and a subsidiary of Institut Mérieux. It is a maker of in vitro diagnostics with a focus on infectious diseases. The company is engaged in manufacturing instruments, chemical reagents, and software systems used by clinical laboratories to test for infections, such as tuberculosis, sepsis, hospital-acquired infections, & AIDS, cardiovascular conditions, and cancer. The company has 19 production sites and 20 R&D sites. bioMérieux is present in 43 countries and distributes its products in 160 countries.

  • F. Hoffmann-La Roche Ltd., F. Hoffmann-La Roche Ltd. is a healthcare company with business operations in the following two divisions: pharmaceuticals and diagnostics. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care. The product portfolio of Roche Diagnostics includes blood glucose meters, point-of-care testing devices, high-throughput analyzers for commercial & hospital diagnostic laboratories, and reagents & instruments for life sciences research. RMD, a segment of Roche Diagnostics, is engaged in the development, manufacture, and distribution of tests based on PCR technology & medical diagnostic products, platforms, and services. RMD’s automated platforms and diagnostic tests focus on areas including virology, genomics & oncology, blood screening tests, HPV & CT/NG, and microbiology. The company caters to a number of clients, including physicians, researchers, laboratories, hospitals, patients, and blood banks.

  • Fluidigm Corporation, Fluidigm Corporation, formerly known as Mycometrix Corporation, manufactures and develops microfluidic systems & technologies for life sciences and applied markets. The company offers consumables and instruments that include high performance. assays for gene expression & genotyping, integrated fluid circuits, and software. Fluidigm Corporation sells its products to agricultural, pharmaceutical & biotechnology companies; clinical research laboratories; and academic institutions. The company provides its 20 innovative solutions & services to 35 countries globally. The technologies provided by Fluidigm allow users to accelerate the development of therapeutics by supporting the identification of meaningful biomarkers.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Real-time PCR, Digital PCR, And End-point PCR Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Real-time PCR, Digital PCR, And End-point PCR Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon